| David L Pollifrone, MD | |
|
11141 Parkview Plaza Dr Ste 325, Fort Wayne, IN 46845-1714 | |
| (260) 425-5400 | |
| (260) 425-5417 |
| Full Name | David L Pollifrone |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | 11141 Parkview Plaza Dr Ste 325, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215901574 | NPI | - | NPPES |
| 0921953 | Medicaid | OH | |
| 0748972 | Medicaid | OH | |
| 000000087511 | Other | IN | ANTHEM BC/BS |
| 100081380 | Medicaid | IN | |
| 200146910 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 01046999A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Dekalb Health | Auburn, IN | Hospital |
| Parkview Noble Hospital | Kendallville, IN | Hospital |
| Parkview Whitley Hospital | Columbia city, IN | Hospital |
| Cameron Memorial Community Hospital Inc | Angola, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Health System Inc | 2163336967 | 1167 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term outcomes from a series of prospective clinical trials of patients age 60 and over who were treated with the mini-transplant, a "kinder, gentler" form of allogeneic (donor cell) stem cell transplantation developed at Fred Hutchinson Cancer Research Center.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 6 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term outcomes from a series of prospective clinical trials of patients age 60 and over who were treated with the mini-transplant, a "kinder, gentler" form of allogeneic (donor cell) stem cell transplantation developed at Fred Hutchinson Cancer Research Center.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 6 days ago
| Entity Name | Northeast Indiana Urology. P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619920295 PECOS PAC ID: 5395641914 Enrollment ID: O20031212000174 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term outcomes from a series of prospective clinical trials of patients age 60 and over who were treated with the mini-transplant, a "kinder, gentler" form of allogeneic (donor cell) stem cell transplantation developed at Fred Hutchinson Cancer Research Center.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David L Pollifrone, MD 11109 Parkview Plaza Dr # 117, Fort Wayne, IN 46845-1701 Ph: () - | David L Pollifrone, MD 11141 Parkview Plaza Dr Ste 325, Fort Wayne, IN 46845-1714 Ph: (260) 425-5400 |
News Archive
PharMerica Corporation, a national provider of institutional pharmacy and hospital pharmacy management services, today announced that its Board of Directors has authorized an increase in its existing share purchase program that will allow the Company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term outcomes from a series of prospective clinical trials of patients age 60 and over who were treated with the mini-transplant, a "kinder, gentler" form of allogeneic (donor cell) stem cell transplantation developed at Fred Hutchinson Cancer Research Center.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
› Verified 6 days ago
Claire Aubrey, D.O Urology Medicare: Accepting Medicare Assignments Practice Location: 2512 E Dupont Rd Ste 110, Fort Wayne, IN 46825 Phone: 260-458-3045 Fax: 260-479-2947 | |
Dr. Sable Paige Locke, M.D. Urology Medicare: Medicare Enrolled Practice Location: 11141 Parkview Plaza Dr Ste 320, Fort Wayne, IN 46845 Phone: 260-425-5400 Fax: 260-425-5417 | |
Michael Rudoff, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 2512 E Dupont Rd Ste 110, Fort Wayne, IN 46825 Phone: 260-458-3045 Fax: 260-479-2947 | |
George W. Bowers, Urology Medicare: Not Enrolled in Medicare Practice Location: 12002 Haddington Court, Fort Wayne, IN 46814 Phone: 260-625-3872 Fax: 260-524-5390 | |
Donald A Urban, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 320, Fort Wayne, IN 46845 Phone: 260-482-8681 Fax: 260-969-0350 | |
Nathan John Locke, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11141 Parkview Plaza Dr Ste 320, Fort Wayne, IN 46845 Phone: 260-425-5400 Fax: 260-425-5417 |